What is Genzyme used for?
Genzyme focuses on six areas of medicine relating to lysosomal storage diseases, renal disease, orthopedics, transplant and immune diseases, oncology, genetics and diagnostics. The first orphan-drug for Genzyme that FDA approved was Ceredase, a drug for treating Gaucher disease.
Why did Sanofi buy Genzyme?
The acquisition gives Sanofi access to Genzyme’s business in treating rare diseases and is expected to help the company combat sales erosion from drugs facing cheap generic competition. Sanofi said more than 237 million Genzyme shares were tendered in the transaction, representing 89.4 percent of outstanding shares.
Who took over Genzyme?
Sanofi-Aventis SA
Sanofi Wins Long-Sought Biotech Deal With its agreement to purchase Genzyme for more than $20 billion, France’s Sanofi-Aventis SA becomes the latest global drug giant to acquire a research base in Cambridge, Mass., one of the industry’s hottest locales for cutting-edge science.
What is a Genzyme test?
Sanofi Genzyme and PerkinElmer Genomics have launched a free genetic testing program that aims to spot certain undiagnosed lysosomal storage disorders, while raising awareness of the group of rare diseases whose symptoms may initially be ascribed to more common ailments.
How do you pronounce Genzyme?
- Phonetic spelling of Genzyme. gen-zyme.
- Meanings for Genzyme. A leading biotechnology company that is located in the United States and was established in the year 1981. Brent Ziemann.
- Examples of in a sentence. New Genzyme pill will cost patients $310250 a year. Muhammad Knight. Genzyme should be in sentence.
Who started Genzyme?
George M. Whitesides
Sheridan Snyder
Genzyme/Founders
Who founded Genzyme?
Is Sanofi a French company?
Sanofi-Aventis, French pharmaceutical company founded in 2004 through the merger of Sanofi-Synthélabo SA and a much larger French firm, Aventis. Primarily focused on the development and sale of prescription medications, Sanofi-Aventis is one of Europe’s largest pharmaceutical firms.
What does Sanofi Genzyme make?
Sanofi develops, manufactures, and distributes healthcare products and pharmaceuticals for diabetes solutions, human vaccines, rare diseases, emerging markets, and consumer healthcare.
Genzyme focuses on six areas of medicine relating to lysosomal storage diseases, renal disease, orthopedics, transplant and immune diseases, oncology, genetics and diagnostics. The first orphan-drug for Genzyme that FDA approved was Ceredase, a drug for treating Gaucher disease.
Who is the founder of Genzyme?
The company was started by Sheridan Snyder and George M. Whitesides in 1981. Genzyme’s scientific founder was Henry Blair who had a contract with the National Institutes of Health (NIH) to produce modified enzymes for the NIH to test in clinical trials.
Does Genzyme own Sygena?
In 1994 Genzyme received FDA approval to market Cerezyme, a genetically engineered replacement for Ceredase. The company acquired Sygena Ltd, BioSurface Technology Inc. and TSI Inc.. TSI was acquired by Genzyme Transgenics Corp. which was 73 percent owned by Genzyme.
Why did Genzyme shut down?
In June 2009, Genzyme’s Allston, Massachusetts plant was shut down to correct a viral contamination (Vesivirus 2117). A similar event had occurred in 2008 at the Geel, Belgium facilities. By April 2010, it had restarted operation at diminished capacity.